{"schema_version":"secwatch.filing_event.v1","accession":"0001549595-25-000105","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2025-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.298759+00:00","generated_at":"2026-05-17T10:33:32.261201+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Nurix director Lori Kunkel resigns; Roy Baynes named committee chair","bullets":["Director Lori A. Kunkel, M.D. resigns from Board and committees effective September 1, 2025.","Resignation not due to any disagreement with company on operations, policies, or practices.","Board appoints Roy D. Baynes, MB.Bch., M.Med., Ph.D., as chair of Clinical and Commercialization Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001549595-25-000105","json":"https://secwatch.observer/filing/0001549595-25-000105.json","markdown":"https://secwatch.observer/filing/0001549595-25-000105.md","text":"https://secwatch.observer/filing/0001549595-25-000105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000154959525000105/0001549595-25-000105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000154959525000105/nrix-20250819.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:33:32.261201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}